U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel)-

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	102 Pages	Coherent Market Insights	September, 2022	CMI17440809

Best Price Guarantee
Price	from $4,500
Length	102 Pages
Publisher	Coherent Market Insights
Published Date	September, 2022
SKU	CMI17440809

U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

A medical food is specifically formulated for patients, who require medical food as a major part of their dietary supplement during treatment. They are custom-made liquid solutions created with the sole purpose of curing persons suffering from various illnesses. Professionals provide the designed meal to people suffering from various illnesses. It is a specially prepared diet that provides patients with adequate nutrients.

Medical foods are available in different forms such as powders, liquids, and even gum. Moreover, medical foods are more commonly used to treat chronic conditions and diseases through long-term use in an outpatient setting. Manufacturers are developing products for new illness indications, fueling growth of the medical food market. Medical food is specifically tailored to meet the nutritional and metabolic demands of those suffering from a specific illness.

Market Dynamics

Medical foods are also used in the treatment of other gastrointestinal diseases such as diarrhea, constipation, gastroenteritis, peptic ulcer diseases, and colorectal cancer, which is expected to propel market growth over the forecast period. Moreover, the increasing geriatric population suffering from several chronic and neurogenic disorders such as dementia, stroke, multiple sclerosis, and difficulty in swallowing requires specific dietary management, which, in turn, is expected to drive the market growth over the forecast period. For instance in July 2019, Georgetown University entered into a collaboration with National Center for Complementary and Integrative Health (NCCIH), University of Maryland, a United States government agency which explores complementary and alternative medicine, initiated early phase 1 clinical trial to demonstrate the mechanisms of preventing antibiotic-associated diarrhea and the role of probiotics.

Key features of the study:

This report provides in-depth analysis of the U.S. Medical Foods market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the U.S. Medical Foods market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The U.S. Medical Foods market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. Medical Foods market

Detailed Segmentation:

U.S. Medical Foods Market, By Food Type:
Prebiotics
Probiotics
Probiotic Foods
Probiotic Supplements
Food Supplements
U.S. Medical Foods Market, By Disease Indication:
Inflammatory Bowel Disease
Ulcerative Colitis
Cohn’s Disease
Irritable Bowel Syndrome
Others
U.S. Medical Foods Market, By Distribution Channel:
Hospitals
Retail Channel
Online Channel
Company Profiles
Enterome SA*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Yakult Honsha Co., Ltd.
Abbott
ExeGi Pharma, LLC.
VSL Pharmaceuticals, Inc.
Entera Health, Inc.
Meiji Holdings Co., Ltd.
Danone
Nestlé S.A.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Food Type  Market Snapshot, By Disease Indication  Market Snapshot, By Distribution Channel o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Recent Product Launch o Epidemiology o Major Brand Analysis o Regulatory Scenario o PEST Analysis 4. U.S. Medical Foods Market- Impact of Coronavirus (Covid-19) Pandemic o Overall Impact o Impact on Supply and Demand o COVID-19 Impact on the market 5. U.S. Medical Foods Market, By Food Type, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Prebiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Probiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Probiotic Foods o Probiotic Supplements o Food Supplements  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 6. U.S. Medical Foods Market, By Disease Indication, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Inflammatory Bowel Disease  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Ulcerative Colitis o Cohn’s Disease o Irritable Bowel Syndrome  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million) o Others  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 7. U.S. Medical Foods Market, By Distribution Channel, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Hospitals  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Retail channel  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Online Channel  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 8. Competitive Landscape o Enterome SA  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Yakult Honsha Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Abbott  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o ExeGi Pharma, LLC.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o VSL Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Entera Health, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Meiji Holdings Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Danone  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Nestlé S.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us *Browse 27 market data tables and 31 figures on "U.S. Medical Foods Market” – U. S. forecast to 2030